Physician profile
Patrick Michael Kozak
NPI 1073900551
$44,397.61
in general payments reported to CMS, 2019-2025
11 companies · $1,061 in 2025
The $1,061 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $529 · 2021: $34K · 2022: $2,227 · 2023: $3,407 · 2024: $2,649 · 2025: $1,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,681 · Food and Beverage: $1,936 · Grant: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,681.28 |
| Food and Beverage | $1,936.36 |
| Grant | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22,530.97 | 2021-2025 | Affera Mapping System, Pulseselect, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $18,720.95 | 2019-2025 | Aveir, Ensite, Viewmate |
| Boston Scientific Corporation | $1,708.72 | 2020-2024 | Watchman Flx, Watchman Access System |
| Biosense Webster, INC. | $363.13 | 2023-2025 | Carto 3, Qdot Micro Catheter, Smartablatetm System Rf Generator |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $340.92 | 2019-2020 | |
| Biotronik INC. | $210.51 | 2020-2025 | Acticor 7 Vr-T Dx, Amvia Edge |
| Atricure, INC. | $208.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $182.94 | 2019-2022 | |
| Abiomed | $102.74 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.54 | 2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $14.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Kozak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.